-
-
-
-
-
-
-
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
-
-
-
-
15,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


